- Home
- ACET vs NHTC Comparison
ACET vs NHTC Comparison
Compare ACET & NHTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACET
- NHTC
- Stock Information
- Founded
- ACET 1947
- NHTC 1988
- Country
- ACET United States
- NHTC United States
- Employees
- ACET N/A
- NHTC N/A
- Industry
- ACET Biotechnology: Pharmaceutical Preparations
- NHTC Diversified Commercial Services
- Sector
- ACET Health Care
- NHTC Miscellaneous
- Exchange
- ACET Nasdaq
- NHTC Nasdaq
- Market Cap
- ACET 64.9M
- NHTC 55.8M
- IPO Year
- ACET N/A
- NHTC 1995
- Fundamental
- Price
- ACET $0.61
- NHTC $4.62
- Analyst Decision
- ACET Buy
- NHTC
- Analyst Count
- ACET 6
- NHTC 0
- Target Price
- ACET $6.00
- NHTC N/A
- AVG Volume (30 Days)
- ACET 398.4K
- NHTC 15.6K
- Earning Date
- ACET 08-12-2025
- NHTC 07-30-2025
- Dividend Yield
- ACET N/A
- NHTC 17.32%
- EPS Growth
- ACET N/A
- NHTC N/A
- EPS
- ACET N/A
- NHTC 0.04
- Revenue
- ACET N/A
- NHTC $42,749,000.00
- Revenue This Year
- ACET N/A
- NHTC N/A
- Revenue Next Year
- ACET N/A
- NHTC N/A
- P/E Ratio
- ACET N/A
- NHTC $115.46
- Revenue Growth
- ACET N/A
- NHTC N/A
- 52 Week Low
- ACET $0.45
- NHTC $4.02
- 52 Week High
- ACET $1.70
- NHTC $7.35
- Technical
- Relative Strength Index (RSI)
- ACET 38.76
- NHTC 52.25
- Support Level
- ACET $0.61
- NHTC $4.27
- Resistance Level
- ACET $0.69
- NHTC $4.48
- Average True Range (ATR)
- ACET 0.04
- NHTC 0.14
- MACD
- ACET -0.01
- NHTC 0.02
- Stochastic Oscillator
- ACET 12.80
- NHTC 70.00
About ACET Adicet Bio Inc.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
About NHTC Natural Health Trends Corp.
Natural Health Trends Corp is an international direct-selling and e-commerce company. It offers a line of products such as Wellness, Herbal, Beauty, Lifestyle, and Home. Wellness products include targeted nutrition for joint health, antioxidant support, digestive health, heart health, and vision health. Herbal products include anti-aging and hydrating cleansers, creams, lotions, serums, and toners. Lifestyle products improve the overall quality of life and to support active, physical and healthy lifestyles. Home products are designed to create a clean and natural living environment for the home. It generates a majority of its revenue from Hong Kong and rest from China, Taiwan, Japan, United States and other regions.